Researchers from USA and Germany developed stem cells that could evade immune attack.

Researchers from the USA in collaboration with some German scientists have developed stem cells that can evade immune attack of the host. They used CRISPR-Cas9 technology to develop the cells.

MHC complex defines whether the cells are your own or foreign. During organ transplantation, MHC of the donor and the recipient should be matched. If there is a mismatch between the two individuals in their MHC, the immune cells of the recipient considers the transplanted organ as foreign and will be destroyed by immune cells. No two individuals have identical MHC complexes. Normally foreign cells are attacked by immune cells. This is the main reason for the difficulty in transplantation.

Using CRISPR, the researcher has deleted the genes that code for MHC complex and as a result, there is no more MHC in the cells. Since there is no more MHC, they are not recognized as foreign and are accepted as their own. One problem is that those cells that have no MHC are the target of another cell called Natural killer(NK) cells. NK cells recognized and kill them. However, when CD47 is expressed on the surface of the cells, it is considered as self and is save from NK cells. The researchers have developed a stem cell that doesn’t have MHC but has CD47 on their surface and transplant those cells using humanized mice model. The studies have found that there is no rejection. This is a huge step in organ transplantation and we could transplant organs even though the MHC does not match which is the main difficulty in transplantation.

References:

1. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.

2. https://doi.org/10.1038/s41587-019-0016-3

Comments

Our top Stories

Biodegradable burial pod turns your body into a tree.

Bretzel and Citelli with Capsula Mundi Model. Whenever a person dies, it is a burden for the family emotionally and financially. We spend thousands of dollars in funerals paying for the casket, flowers, and monuments. Environmentally, those caskets and monuments left behind an enormous carbon footprint. Recently, many people have begun to embrace the idea of green burials. People are environmentally more aware and there is a shift from cremation and the use of wood, the synthetic cushioning and the metals generally used in traditional coffins to green burial. Green burial is a method of burying the body in a wooden coffin without a concrete burial vault. The body along with the wooden coffin is degraded easily by the bacteria in the soil. This type of burial allows the graveyard to return to nature. Nearly 54 percent of Americans are considering green burial and 74 percent of cemeteries are reporting an increased demand for g...

Scientists found two anti-viral drugs which kills novel coronavirus (2019-nCOV).

The recent outbreak of coronavirus in Wuhan has infected thousands of people, especially in China. As of till now 30,00 confirmed cases have been reported in mainland China. Additionally, imported cases of coronavirus were identified in many other countries including Thailand, Japan, South Korea, United States, Vietnam, Singapore, Nepal, India, France, Australia, and Canada. The cause of the outbreak has been named novel coronavirus (2019- nCoV ). This virus belongs to the same family as SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV) which cause epidemic and killed many in the early 2000s. The virus is spreading everywhere infecting thousands of innocent people. But there is no drug available for treatment. Scientists around the globe are working their best to develop a drug for the treatment of infected patients. The quickest solution is to check whether we can treat patients using the drugs that are currently available for treating ...

Scientist who developed India’s first indigenous vaccine dies at the age of 72.

Dr. M.K. Bhan addressing a Press Conference to apprise on the two significant R&D results emanating from DBT support, in New Delhi on May 31, 2012. The scientist who developed India’s first indigenous vaccine dies at 72. He was born in 1947, the year when India got independence and he passes away on 26th January, when India was celebrating its 71st Republic day. He was destined to be part of the country’s history. Maharaj Kishan Bhan is an Indian pediatrician and clinical scientist who developed the vaccine for rotavirus, the first indigenous vaccine produced in the country. He was born on 9th November 1947. He completed his MBBS degree from AFMC, Pune and M.D. Degree from Post Graduate Institute of Medical Education and Research, Chandigarh. As a faculty in AIIMS, Delhi he worked extensively on childhood diarrhea and nutrition. Childhood diarrhea is ...

Story of Kary Mullis, PCR inventor

'Sometimes a great idea comes to you when you are not looking for it' 'Science is subject to arbitrary fashion' 'Science grows like a weed every year' Kary Mullis at TED talk. Kary Mullis, inventor of PCR was born on 28 December 1944 in North Carolina, USA. His parents grew up in the foothills of Blue ridge Mountains. And they live near their grandfather’s farm. Kary Mullis was an eight-year-old boy when Watson and Crick published the structure of DNA in 1953. By the time Watson and Crick were awarded Nobel prize, Kary was still busy designing rockets in Georgia Institute of Technology. He was not interested in studying DNA at all. By the time he left Georgia Tech, biologists had already solved the genetic code. It was during his six years at UC, Berkley as a Ph.D. student that changes his mind. After six years at Berkley with a Ph.D., he headed to Kansas to become a writer. He quickly found out he was too young to be a writer and was poor...

Top 5 public companies working on gene editing.

Top 5 public companies working on gene editing . The ranking based on the revenues generated in 2018. 1. Sangamo Therapeutics: $84.5million This is an American biotechnology company. They apply cell and gene therapy to combat hemophilia and other genetic diseases. They base the company in California, USA. They develop Zinc Finger gene-editing technology. Clinical trials involving gene editing using Zinc Finger Nuclease (ZFN) are ongoing. Sangamo therapeutics building 2. Horizon Discovery Group: $73.7m It is a gene-editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications that advance human health. They used three gene-editing tools CRISPR, ZFN, and recombinant A deno -associated virus ( rAAV ). The company saw a 68% rise in revenue. The revenue was £58.7million and based in Waterbeach, United Kingdom. Horizon discovery group main building 3...

Science Stories

Search This Blog